Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512
Table 1
Baseline Characteristics and Demographics of 24 Evaluable Patients.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Baseline Characteristics and Demographics of 24 Evaluable Patients.